RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Calyx focused on oral therapies for diabetes and inflammatory diseases, utilizing natural plant extracts with demonstrated clinical activity in humans as the source of its discovery efforts. Working with this company, Pappas Ventures expanded our expertise in oral therapies. Theracos acquired the company’s assets in 2003.
Calyx Therapeutics
Hayward, CA
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.